Chemically induced analgesic nephropathy in the rat monitored by proton- electron double-resonance imaging (PEDRI)

Magnetic Resonance in Medicine

Volumn 40, Issue 2, 1998, Pages 280-286

  Seimenis, Ioannis ^a   Foster, Margaret A ^a   Lurie, David J ^a   Hutchison, James M S ^b   Whiting, Paul H ^a   Payne, Simon ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b NONE

Author keywords

Analgesic nephropathy; PCA; PEDRI; Renal papillary necrosis

Indexed keywords

BLOOD VESSELS; CELL DEATH; FREE RADICALS; HISTOLOGY; TISSUE;

AFTER-TREATMENT; CLEARANCE RATES; NEPHROPATHY; NITROXIDE FREE RADICALS; PEDRI; PROTON ELECTRON DOUBLE RESONANCE IMAGING; RENAL FUNCTIONS; RENAL PAPILLARY NECROSIS;

RATS;

2 BROMOETHYLAMINE; 3 CARBOXY 2,2,5,5 TETRAMETHYLPYRROLIDINE 1 OXYL; ANALGESIC AGENT; FREE RADICAL; NITROXIDE; SODIUM CHLORIDE;

ANALGESIC NEPHROPATHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; HALF LIFE TIME; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY CLEARANCE; KIDNEY CORTEX; KIDNEY FUNCTION; KIDNEY MEDULLA; KIDNEY PAPILLA NECROSIS; KIDNEY TUBULE DAMAGE; MALE; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; URINARY EXCRETION;

EID: 0031859411     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrm.1910400214     Document Type: Article

References (26)

1. R. S. Nanra, Analgesic-associated nephropathies, in "Massry and Glassock's Textbook of Nephrology" (S. G. Massry, R. J. Glassock, Eds.), pp. 963-970. Williams & Wilkins. Baltimore. 1995.
2. A. F. Burry, The evolution of analgesic: nephropathy. Nephron 5, 185-201 (1968).
3. U. Bengtsson, A comparative study of chronic non-obstructive pyelonephritis and renal papillary necrosis. Acta Med. Scand. 388(Suppl.), 171 (1962).
4. J. R. Cove-Smith, M. S. Knapp. Sodium handling in analgesic nephropathy. Lancet 2, 70-72 (1973).
5. P. H. Bach, T. L. Hardy, Relevance of animal models to analgesic-associated renal papillary necrosis in humans. Kidney Int. 28, 605-613 (1985).
6. G. Murray, R. G. Wyllie, G. S. Hill, P. W. Ramsden, R. H. Heptinstall, Experimental papillary necrosis of the kidney. I. Morphologic and functional data. Am. J. Pathol 67, 285-297 (1972).
7. S. Sabatini, The pathophysiology of experimentally induced papillary necrosis. Semin. Nephrol. 4, 27-39 (1984).
8. S. Sabatini, S. Koppera, J. Manaligod, J. A. L. Arruda, N. A. Kurtzman, Role of urinary concentrating ability in the generation of toxic papillary necrosis. Kidney Int. 23, 705-710 (1983).
9. D. J. Lurie, D. M. Bussell, L. H. Bell, J. R. Mallard, Proton electron double magnetic resonance imaging of free radicals solutions. J. Magn. Reson. 76, 366-370 (1988).
10. I. Seimenis, M. A. Foster, D. J. Lurie, J. M. S. Hutchison, P. H. Whiting, S. Payne, The excretion mechanism of the spin label proxyl carboxylic acid (PCA) from the rat monitored by X-band ESR and PEDRI. Magn. Reson. Med. 37, 552-558 (1997).
11. W. R. Couet, U. G. Eriksson, T. N. Tozer, L. D. Tuck, G. E. Wesbey, D. Nitecki, R. C. Brasch, Pharmacokinetics and metabolic fate of two nitroxides potentially useful as contrast agents for magnetic resonance imaging. Pharmacol. Res. 5, 203-209 (1984).
12. R. L. Ehman, G. E. Wesbey, K. L. Moon, R. D. Williams, M. T. McNamara, W. R. Couet, T. N. T. N. Tozer, R. C. Brasch, Enhanced MRI of tumors utilizing a new nitroxyl spin-label contrast agent. Magn. Reson. Imaging 3, 89-97 (1985).
13. J. F. W. Keana, S. Pou, G. M. Rosen, Nitroxides as potential contrast enhancing agents for MRI application: influence of structure on the rate of reduction by rat hepatocytes, whole liver homogenate, subcellular fractions, and ascorbate. Magn. Reson. Med. 5, 525-536 (1987).
14. V. Afzal, R. C. Brasch, D. E. Nitecki, S. Wolff, Nitroxyl spin label contrast enhancers for magnetic resonance imaging: studies of acute toxicity and mutagenesis. Invest. Radiol. 19, 549-552 (1984).
15. G. Sosnovskv, A critical evaluation of the present status of toxicity of amidoxyl radicals. J. Pharmacol. Sci. 81, 496-499 (1992).
16. D. J. Lurie, I. Nicholson, Proton-electron double-resonance imaging of exogenous and endogenous free radicals in vivo, in "Proceedings of the International School of Physics Enrico Fermi" (B, Maraviglia, Ed.), pp. 485-503, North-Holland, Amsterdam, 1993.
17. I. Seimenis, "The Efficacy of MR Techniques in the Detection and Assessment of Renal Injury in Clinically Relevant Animal Models of Renal Disease," Doctoral Thesis, University of Aberdeen, Aberdeen, Scotland, 1997.
18. J. M. S. Hutchison, W. A. Edelstein, G. Johnson, A whole-body NMR imaging machine. J. Phys. E. Scient. Instrum. 13, 947-955 (1980).
19. D. W. Alderman, D. M. Grant, An efficient decoupler coil design which reduces heating in conductive samples in superconducting spectrometers. J. Magn. Reson. 36, 447-451 (1979).
20. D. R. Sadler, "Numerical Methods for Nonlinear Regression," University of Queensland Press, St. Lucia, 1975.
21. T. O. Tiffany, J. M. Jansen, C. A. Burtis, J. B. Overton, C. D. Scott, Enzymatic kinetic rate and end-point analyses of substrate, by use of a GeMSAEC fast analyzer. Clin. Chem. 18, 829-840 (1972).
22. I. Nicholson, "Proton Electron Double Resonance Imaging of Free Radicals," Doctoral Thesis, University of Aberdeen, Aberdeen, Scotland, 1992.
23. K. J. Ullrich, Specificity of transporters of organic anions and organic cations in the kidney. Biochim. Biophys. Acta 1197, 45-62 (1994).
24. P. H. Bach, P. Grasso, E. A. J. W. Molland, Changes in medullary glycosaminoglycan histochemistry and microvascular filling during the development of 2-bromoethanamine hydrobromide-induced renal papillary necrosis. Toxicol. Appl. Pharmacol., 69, 333-344 (1983).
25. D. J. Davies, J. D. Tange, Factors influencing the severity and progress of ethylenimine-induced papillary necrosis. Pathology 137, 305-314 (1982).
26. F. E. Cuppage, A. Tate, Repair of the rat kidney following papillary necrosis produced by bromoethylamine hydrobromide. Lab. Invest. 31, 593-601 (1974).